These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25395346)

  • 1. Mexico's "ley de narcomenudeo" drug policy reform and the international drug control regime.
    Mackey TK; Werb D; Beletsky L; Rangel G; Arredondo J; Strathdee SA
    Harm Reduct J; 2014 Nov; 11(1):31. PubMed ID: 25395346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking 'flexibilities' in the international drug control system-Potential, precedents and models for reforms.
    Collins J
    Int J Drug Policy; 2018 Oct; 60():107-114. PubMed ID: 28129946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring improvement in knowledge of drug policy reforms following a police education program in Tijuana, Mexico.
    Arredondo J; Strathdee SA; Cepeda J; Abramovitz D; Artamonova I; Clairgue E; Bustamante E; Mittal ML; Rocha T; Bañuelos A; Olivarria HO; Morales M; Rangel G; Magis C; Beletsky L
    Harm Reduct J; 2017 Nov; 14(1):72. PubMed ID: 29117858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The law on the streets: Evaluating the impact of Mexico's drug decriminalization reform on drug possession arrests in Tijuana, Mexico.
    Arredondo J; Gaines T; Manian S; Vilalta C; Bañuelos A; Strathdee SA; Beletsky L
    Int J Drug Policy; 2018 Apr; 54():1-8. PubMed ID: 29306177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.
    Robertson AM; Garfein RS; Wagner KD; Mehta SR; Magis-Rodriguez C; Cuevas-Mota J; Moreno-Zuniga PG; Strathdee SA;
    Harm Reduct J; 2014 Feb; 11():4. PubMed ID: 24520885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The political and socioeconomic context of legal and illegal Mexican migration to the United States (1942-1984).
    Hansen LO
    Int Migr; 1988 Mar; 26(1):95-107. PubMed ID: 12281024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexico's drug policy reform: cutting edge success or crisis in the making?
    Werb D; Mora ME; Beletsky L; Rafful C; Mackey T; Arredondo J; Strathdee SA
    Int J Drug Policy; 2014 Sep; 25(5):823-5. PubMed ID: 24974368
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington, and Uruguay.
    Pardo B
    Int J Drug Policy; 2014 Jul; 25(4):727-35. PubMed ID: 24970383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards revision of the UN drug control conventions: harnessing like-mindedness.
    Bewley-Taylor DR
    Int J Drug Policy; 2013 Jan; 24(1):60-8. PubMed ID: 23036654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UNGASS 2016: Insights from Europe on the development of global cannabis policy and the need for reform of the global drug policy regime.
    Chatwin C
    Int J Drug Policy; 2017 Nov; 49():80-85. PubMed ID: 26795703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexico's precursor chemical controls: emergence of less potent types of methamphetamine in the United States.
    Cunningham JK; Maxwell JC; Campollo O; Liu LM; Lattyak WJ; Callaghan RC
    Drug Alcohol Depend; 2013 Apr; 129(1-2):125-36. PubMed ID: 23127541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regime change: re-visiting the 1961 Single Convention on Narcotic Drugs.
    Bewley-Taylor D; Jelsma M
    Int J Drug Policy; 2012 Jan; 23(1):72-81. PubMed ID: 21996163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The international dimension of drug policy reform in Uruguay.
    von Hoffmann J
    Int J Drug Policy; 2016 Aug; 34():27-33. PubMed ID: 27233516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global drug policy at an impasse: Examining the politics of the 2016 United Nations General Assembly Special Session.
    Sischy J; Blaustein J
    Int J Drug Policy; 2018 Oct; 60():74-81. PubMed ID: 30173003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Policy and the Public Good: a summary of the book.
    Drugs and Public Policy Group
    Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opium, tobacco and alcohol: the evolving legitimacy of international action.
    McKee M
    Clin Med (Lond); 2009 Aug; 9(4):338-41. PubMed ID: 19728506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degeneration and the origins of Mexico's war on drugs.
    Campos I
    Mex Stud; 2010; 26(2):379-408. PubMed ID: 20821890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Institutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reform.
    Werb D; Strathdee SA; Meza E; Rangel Gomez MG; Palinkas L; Medina-Mora ME; Beletsky L
    Glob Public Health; 2017 May; 12(5):519-530. PubMed ID: 28278755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do international model drug control laws provide for drug availability?
    University of Wisconsin Pain & Policy Studies Group
    J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could cannabis liberalisation lead to wider changes in drug policies and outcomes?
    Hughes B; Wiessing L; Des Jarlais D; Griffiths P
    Int J Drug Policy; 2018 Jan; 51():156-159. PubMed ID: 29229491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.